Serveur d'exploration sur les pandémies grippales - Checkpoint (Istex)

Index « Teeft.i » - entrée « Antibody titer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antibody therapy < Antibody titer < Antibody titers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000413 (2013) V. Vamsee Aditya Mallajosyula [Inde] ; Michael Citron ; Xianghan Lu ; Jan Ter Meulen ; Raghavan Varadarajan [Inde] ; Xiaoping Liang [Inde]In vitro and in vivo characterization of designed immunogens derived from the CD‐helix of the stem of influenza hemagglutinin
000527 (2013) Alper Azak ; Bülent Huddam ; Gülay Kocak ; A Basak Altas [Turquie] ; Murat Duranay ; Gülay Korukluoglu [Turquie]Antibody Response After Single H1N1 Influenza Vaccine in Chronic Dialysis Patients
000776 (2012) Shingo Uno ; Kazuhiko Kimachi ; Fujio Matsuo [Japon] ; Keiichiro Miyazaki ; Ayano Oohama ; Junko Kei ; Tomohiro Nishimura ; Koichi Odoh ; Yoichiro KinoCross‐reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan
000C68 (2010) Marc-André D Oust ; Manon M. Couture ; Nathalie Charland ; Sonia Trépanier ; Nathalie Landry ; Frédéric Ors ; Louis-P. VézinaThe production of hemagglutinin‐based virus‐like particles in plants: a rapid, efficient and safe response to pandemic influenza
000D02 (2010) Gannon C. Mak [Hong Kong] ; Perrin W. W. Choy [Hong Kong] ; W. Y. Lee [Hong Kong] ; Ann H. Wong [Hong Kong] ; K. C. Ng [Hong Kong] ; Wilina Lim [Hong Kong]Sero‐immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong
000E01 (2010) Daisuke Ikeno ; Kazuhiko Kimachi ; Yoichiro Kino ; Seiichi Harada ; Kayo Yoshida ; Shinji Tochihara ; Shigeyuki Itamura ; Takato Odagiri ; Masato Tashiro ; Kenji Okada ; Chiaki Miyazaki ; Kohji Ueda [Japon]Immunogenicity of an inactivated adjuvanted whole‐virion influenza A (H5N1, NIBRG‐14) vaccine administered by intramuscular or subcutaneous injection
000E02 (2010) Hidetoshi Igari [Japon] ; Shunsuke Segawa [Japon] ; Akira Watanabe [Japon] ; Akiko Suzuki [Japon] ; Mariko Watanabe [Japon] ; Takayuki Sakurai [Japon] ; Fuminobu Kuroda [Japon] ; Masaharu Watanabe [Japon] ; Koichiro Tatsumi [Japon] ; Mikio Nakayama [Japon] ; Toshinori Nakayama [Japon] ; Kazuo Suzuki [Japon] ; Takeyuki Sato [Japon]Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health‐care workers of a university hospital in Japan
001152 (2009) Mali Wirotesangthong [Thaïlande] ; Takayuki Nagai [Japon] ; Haruki Yamada [Japon] ; Surattana Amnuoypol [Thaïlande] ; Chutichot Mungmee [Thaïlande]Effects of Clinacanthus siamensis leaf extract on influenza virus infection
001734 (2006) Chuanling Qiao [République populaire de Chine] ; Guobin Tian [République populaire de Chine] ; Yongping Jiang [République populaire de Chine] ; Yanbing Li [République populaire de Chine] ; Jianzhong Shi [République populaire de Chine] ; Kangzhen Yu [République populaire de Chine] ; Hualan Chen [République populaire de Chine]Vaccines Developed for H5 Highly Pathogenic Avian Influenza in China
001D68 (2000) J. M. Katz [États-Unis] ; X. Lu ; A. M. Frace [États-Unis] ; T. Morken [États-Unis] ; S. R. Zaki [États-Unis] ; T. M. Tumpey [États-Unis]Pathogenesis of and immunity to avian influenza A H5 viruses
002153 (1987) Craig M. Pease [États-Unis]An evolutionary epidemiological mechanism, with applications to type a influenza
002258 (1980) Kohji Ueda [Japon] ; Sankei Nishima [Japon] ; Hiroshi Fujii [Japon] ; Hakaru Tasaki [Japon] ; Mitsuo Sako [Japon] ; Saneo Nonaka [Japon]An influenza Epidemic among Institutionalized Children at the Time of Replacement from A(H3N2)to A(H1N1): Observation of 32 Cases Including 3 Cases of Probable Simultaneous Infection with A(H1N1) and A(H3N2)
002304 (1977) Mary J. Spencer [États-Unis] ; James D. Cherry [États-Unis] ; Keith R. Powell [États-Unis] ; M. Ray Mickey [États-Unis] ; Paul I. Terasaki [États-Unis] ; S. Michael Marcy [États-Unis] ; Ciro V. Sumaya [États-Unis]Antibody responses following rubella immunization analyzed by HLA and ABO types

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Antibody titer" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Antibody titer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Antibody titer
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021